Programmes

Market Access Academy

  • Executive
  • LSE Health
  • Application code EE910
  • Starting 2019
  • Short course: Open
  • Location: London

Created in collaboration with The Boston Consulting Group (BCG) and leading pharmaceutical companies from around the world, this intensive course connects pharmaceutical management with advanced knowledge and strategies in market access.

5 day intensive programme running 1 - 5 April and 9 - 13 September 2019

The Market Access Academy is aimed at present and future Access Leaders within the pharmaceutical industry. Based on key business needs, it will provide participants with a common grounding in market access, training in representative decision-making across the product life-cycle, and strategies to adapt to a rapidly changing industry landscape.

We have a highly developed programme of lectures, case studies, workshops, and notable guest speakers. This bespoke selection provides technical experts - as well as those from other functions - the tools to understand the market access environment, plan strategy, and optimise access and value.

What will Access Leaders gain?

  • A common grounding in market access.
  • Training in representative decision-making across the product life-cycle.
  • Strategies to adapt to a changing landscape.
  • Five days of lectures, case studies, workshops and VIP guest speakers.

Tuition Fee:

  • Market Access Roundtable Members: £6,795
  • Non-Market Access Roundtable Members: £6,995

Includes all LSE tuition, course materials, daily lunches, and networking events. You will also be awarded an LSE certificate of completion at the end of the five days.

Part of LSE Executive Education Courses

Programme details

Programme structure

The Academy is taught over five days and is a mix of lectures, panel speakers, and interactive case studies:

Module 1: Understanding access, drivers, and barriers
Learning objectives: Understanding of key leverage points (evidence, non-evidence) used to optimise P&R outcomes across different in-scope markets and TAs.

Module 2: Defining an integrated evidence package
Learning objectives: Navigating challenges and trade-offs (internal and external) for successful decision-making in evidence-generation planning and synthesis.

Module 3: Creating a receptive access environment
Learning objectives: Identifying key relevant stakeholders and assessing different non-evidence access levers enabling Access Leaders to develop a broader stakeholder engagement plan beyond HTAs and payers. This module focuses on the importance of market access stakeholders, the role of patient organisations, and utilising collaborative negotiations to realise success.

Module 4: Optimising access and value
Learning objectives: Developing a successful strategic P&R approach by understanding the overall option space, trade-offs and most relevant tools. The module provides participants with the technical functional expertise needed to develop P&R strategies and then expands on how to build an effective pricing strategy in three parts, with focus on the payer and industry perspectives.

Module 5: Managing access strategy and execution
Learning objectives: Understanding the behaviours and tools of successful cross-functional Access Leaders, as seen by executives and senior internal clients.

 

Course outcomes

During the course's highly interactive five days, participants will:

  • Learn representative decision-making as Access Leaders, including how to frame and address business requirements/issues.
  • Understand the functional, technical access competencies (policy, evidence generation etc.) and the roles they play in business decisions.
  • Deepen understanding of evolving access-relevant trends and access landscape/environment.
  • Network with pharmaceutical executives, industry professionals from Health Technology Assessment (HTA) bodies, key policy makers and more.

Find out more about the experiences of our participants.

Faculty and guest speakers

The course will be taught by:

  • Professor Elias Mossialos, Director, LSE Health
  • Dr Panos Kanavos, Deputy Director, LSE Health, Programme Director at Medical Technology Research Group
  • Professor Alistair McGuire, Chair, LSE Health
  • Professor Allan Hackshaw, UCL, Professor of Epidemiology and Medical Statistics, CRUK Cancer Trials Centre

Find out more about the academic team on the course.

VIP guest speakers from past courses

  • Nigel Edwards, Chief Executive, Nuffield Health
  • Leeza Osipenko, Associate Director, Scientific Advice, National Institute for Health and Care Excellence (NICE)
  • Dr Richard Torbett, Executive Director - Commercial Policy: UK and International, Association of the British Pharmaceutical Industry (ABPI)
  • Robert Madelin, Senior Advisor for Innovation, European Political Strategy Centre (EPSC), United Kingdom
  • Francis Arickx, Institut National d'Assurance Maladie-Invalidité (INAMI), Belgium
  • Sheela Upadhyaya, Associate Director - Highly Specialised Technologies, NICE, United Kingdom
  • Finn Børlum Kristensen, Managing Director - Science & Policy, Hilleroed, Denmark

Collaborative-partners

The London School of Economics and Political Science (LSE) and The Boston Consulting Group (BCG) have partnered with AbbVie, AstraZeneca, Amgen, Bayer, Eli Lilly, Janssen, Merck EMD, Pfizer, Roche, Sanofi, Takeda, UCB, and members of the BCG Market Access Roundtable, to create Market Access Academy, the first collaborative market access management development programme.

The Academy has been jointly developed by:

  • Latif Akintade, Vice President, Head of Global Market Access, AbbVie
  • Indranil Bagchi, Senior Vice President and Head, Global Value & Access, Novartis
  • Wolfgang Berger, Head of Global Pricing & Market Access Neuroscience, Roche
  • Ana Cespedes, Senior Vice President, Head of Global Market Access and Pricing, Merck
  • Carmelo Formica, Former Vice President, Head of Global Market Access, Takeda
  • David Greber, Partner and Managing Director, The Boston Consulting Group
  • Jens Grueger, Head Global Pricing & Market Access, Roche
  • Sophie Janssens, Vice President and Global head Real World Evidence, UCB
  • Andrew Karazim, Senior Director, Global Pricing, Reimbursement and Access, Eli Lilly
  • Jonathan Plumb, Head, Global Real-World Data & Evidence Sciences, UCB
  • Herb Riband, Vice President Value Access & Policy, Amgen
  • Anne-Toni Rodgers, Former Head of Operations, Global Payer Evidence and Pricing, AstraZeneca
  • Michael Steelman, Vice President, Head of Global Pricing, Sanofi
  • Ludwig Steindl, Head Market Access Pulmonology and Innovative Women's Health Care, Bayer
  • Karin Steinmann, Director Value Access & Policy Europe, Amgen
  • Koen Torfs, Vice President Global Reimbursement and Real World Evidence, Janssen
  • Srikant Vaidyanathan, Partner and Managing Director, The Boston Consulting Group

Entry requirements

Executive Education Courses are taught to the School's high standard and are therefore academically rigorous. Participants are expected to be fluent in English, with a good first degree in a relevant subject. 

The Market Access Academy is tailored towards access new starters. Our target participant profile is an individual who meets the following criteria:

  • Minimum of five years’ experience post-university.
  • Leadership experience in other functions, with a look to gain Access exposure.
  • Limited/or very specific Access experience, which lacks the broader view.
  • Recently became (<1 year), or will become, Global Access Leads in the near future.
  • Fluency in English

More information about LSE Executive Education Courses.

Register for a personal consultation

Sign up for more information

Sign up for more information

  • When would you like to attend?
  • Your privacy
  • Your right to privacy is important to us. The personal information that you submit in this form will be used to provide you with information about Executive Education courses at LSE that may be of interest to you. Please visit lse.ac.uk/privacy to read our Privacy Policy and learn more about how we collect and use information about you so that you can make an informed choice about using our website.
  • Would you like to receive emails from LSE Executive Education Courses?
  • Untitled

Download our course brochure

Download our course brochure

  • When would you like to attend?
  • Your privacy
  • Your right to privacy is important to us. The personal information that you submit in this form will be used to provide you with information about Executive Education courses at LSE that may be of interest to you. Please visit lse.ac.uk/privacy to read our Privacy Policy and learn more about how we collect and use information about you so that you can make an informed choice about using our website.
  • Would you like to receive emails from LSE Executive Education Courses?

How to apply

How to apply

  • Personal details
  • Do you have any international work experience?
  • Please choose your preferred programme date
  • Contact details
  • Address
  • Terms and conditions
  • Payment
    Please read the terms and conditions (listed in the site menu)
  • Fee
  • Payment method
  • Is your billing address the same as above?
  • Please add your billing address if different from above.
  • Privacy statement
  • Your right to privacy is important to us. The personal information that you submit in this form will be used to provide you with information about Executive Education courses at LSE that may be of interest to you. Please visit lse.ac.uk/privacy to read our Privacy Policy and learn more about how we collect and use information about you so that you can make an informed choice about using our website.
  • Would you like to receive emails from LSE Executive Education Courses?

Related programmes

Executive Achieving Leadership Excellence (2018)

Short courses — Code(s) EE901

Executive Changing Minds, Behaviours and Decisions (2018)

Short courses — Code(s) EE909

Executive Data Science for Decision Making (2018)

Short courses — Code(s) EE908

Executive Designing Strategy for Competitive Advantage (2019)

Short courses — Code(s) EE902

Executive Entrepreneurship and Innovation in the Age of Change (2018)

Short courses — Code(s) EE907

Request a prospectus

  • Name
  • Address

Register your interest

  • Name

Speak to Admissions

Content to be supplied